Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 161

    1.

    Proton pump inhibitors and risk of upper gastrointestinal bleeding in NSAID users.

    Ibáñez L, Vidal X, Laporte JR.

    Am J Gastroenterol. 2008 Oct;103(10):2658-9. No abstract available. PMID: 18855866 [PubMed - indexed for MEDLINE]Related articles

    2.

    Proton Pump Inhibitors and Risk of Upper Gastrointestinal Bleeding in NSAID Users.

    Ibáñez L, Vidal X, Laporte JR.

    Am J Gastroenterol. 2008 Aug 5. [Epub ahead of print] No abstract available. PMID: 18684192 [PubMed - as supplied by publisher]Related articles

    3.

    Epidemiology of aplastic anemia: a prospective multicenter study.

    Montané E, Ibáñez L, Vidal X, Ballarín E, Puig R, García N, Laporte JR; Catalan Group for Study of Agranulocytosis and Aplastic Anemia.

    Haematologica. 2008 Apr;93(4):518-23. Epub 2008 Mar 5.PMID: 18322256 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Agranulocytosis induced by nonchemotherapy drugs.

    Ibáñez L, Vidal X, Laporte JR.

    Ann Intern Med. 2008 Feb 19;148(4):319-20; author reply 320-1. No abstract available. PMID: 18283211 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Risk of upper gastrointestinal bleeding and the degree of serotonin reuptake inhibition by antidepressants: a case-control study.

    Vidal X, Ibáñez L, Vendrell L, Conforti A, Laporte JR; Spanish-Italian Collaborative Group for the Epidemiology of Gastrointestinal Bleeding.

    Drug Saf. 2008;31(2):159-68.PMID: 18217791 [PubMed - indexed for MEDLINE]Related articles

    6.

    Use of granulocyte colony-stimulating factor (G-CSF) and outcome in patients with non-chemotherapy agranulocytosis.

    Ibáñez L, Sabaté M, Ballarín E, Puig R, Vidal X, Laporte JR; Agranulocytosis and Aplastic Anaemia Study Group of Barcelona.

    Pharmacoepidemiol Drug Saf. 2008 Mar;17(3):224-8.PMID: 18181220 [PubMed - indexed for MEDLINE]Related articles

    7.

    European commission consultation on pharmacovigilance.

    Waller P, Beard K, Egberts T, Evans S, Hallas J, Hasford J, Laporte JR, Moore N, Shakir S, Sturkenboom M.

    Pharmacoepidemiol Drug Saf. 2008 Feb;17(2):108-9. No abstract available. PMID: 18058839 [PubMed - indexed for MEDLINE]Related articles

    8.

    Risk of acute liver injury associated with the use of drugs: a multicentre population survey.

    Sabaté M, Ibáñez L, Pérez E, Vidal X, Buti M, Xiol X, Mas A, Guarner C, Forné M, Solà R, Castellote J, Rigau J, Laporte JR.

    Aliment Pharmacol Ther. 2007 Jun 15;25(12):1401-9.PMID: 17539979 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Analgesics for pain after traumatic or orthopaedic surgery: what is the evidence--a systematic review.

    Montané E, Vallano A, Aguilera C, Vidal X, Laporte JR.

    Eur J Clin Pharmacol. 2006 Nov;62(11):971-88. Epub 2006 Sep 21. Review.PMID: 17019588 [PubMed - indexed for MEDLINE]Related articles

    10.

    Utilisation of antihyperglycaemic drugs in ten European countries: different developments and different levels.

    Melander A, Folino-Gallo P, Walley T, Schwabe U, Groop PH, Klaukka T, Vallano A, Laporte JR, Gallego MR, Schiappa M, Røder M, Kampmann JP, de Swaef A, Aberg M, Månsson NO, Lindblad U.

    Diabetologia. 2006 Sep;49(9):2024-9. Epub 2006 Jul 25.PMID: 16865360 [PubMed - indexed for MEDLINE]Related articles

    11.

    Upper gastrointestinal bleeding associated with antiplatelet drugs.

    Ibáñez L, Vidal X, Vendrell L, Moretti U, Laporte JR; Spanish-Italian Collaborative Group for the Epidemiology of Gastrointestinal Bleeding.

    Aliment Pharmacol Ther. 2006 Jan 15;23(2):235-42.PMID: 16393302 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Relative incidence of agranulocytosis and aplastic anemia.

    Kaufman DW, Kelly JP, Issaragrisil S, Laporte JR, Anderson T, Levy M, Shapiro S, Young NS.

    Am J Hematol. 2006 Jan;81(1):65-7.PMID: 16369972 [PubMed - indexed for MEDLINE]Related articles

    13.

    Topiramate in non-approved indications and acute myopia or angle closure glaucoma.

    Cereza G, Pedrós C, Garcia N, Laporte JR.

    Br J Clin Pharmacol. 2005 Nov;60(5):578-9. Review. No abstract available. PMID: 16236051 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Cyanamide-induced aplastic anemia.

    Ballarín E, Ibáñez L, Hernández JA, Force L, Laporte JR.

    Eur J Clin Pharmacol. 2005 Jul;61(5-6):467-9. Epub 2005 Jul 1.PMID: 15991038 [PubMed - indexed for MEDLINE]Related articles

    15.

    Case-control study of regular analgesic and nonsteroidal anti-inflammatory use and end-stage renal disease.

    Ibáñez L, Morlans M, Vidal X, Martínez MJ, Laporte JR.

    Kidney Int. 2005 Jun;67(6):2393-8.PMID: 15882284 [PubMed - indexed for MEDLINE]Related articles

    16.

    Population-based drug-induced agranulocytosis.

    Ibáñez L, Vidal X, Ballarín E, Laporte JR.

    Arch Intern Med. 2005 Apr 25;165(8):869-74.PMID: 15851637 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Treatment of type 2 diabetes in primary health care: a drug utilization study.

    Mino-León D, Figueras A, Amato D, Laporte JR.

    Ann Pharmacother. 2005 Mar;39(3):441-5. Epub 2005 Feb 8.PMID: 15701767 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Therapeutic use of cannabis: results of a prospective survey in Catalonia (Spain)]

    Duran M, de Las Heras MJ, Laporte JR, Capellà D.

    Med Clin (Barc). 2005 Jan 22;124(2):76-7. Spanish. No abstract available. PMID: 15691441 [PubMed - indexed for MEDLINE]Related articles

    19.

    Agranulocytosis associated with dipyrone (metamizol).

    Ibáñez L, Vidal X, Ballarín E, Laporte JR.

    Eur J Clin Pharmacol. 2005 Jan;60(11):821-9. Epub 2004 Dec 3.PMID: 15580488 [PubMed - indexed for MEDLINE]Related articles

    20.

    Oral antispastic drugs in nonprogressive neurologic diseases: a systematic review.

    Montané E, Vallano A, Laporte JR.

    Neurology. 2004 Oct 26;63(8):1357-63. Review.PMID: 15505149 [PubMed - indexed for MEDLINE]Related articles

    21.

    Medical speciality and pattern of medicines prescription.

    Vallano A, Montané E, Arnau JM, Vidal X, Pallarés C, Coll M, Laporte JR.

    Eur J Clin Pharmacol. 2004 Dec;60(10):725-30. Epub 2004 Oct 16.PMID: 15502994 [PubMed - indexed for MEDLINE]Related articles

    22.

    Incidence of agranulocytosis in Southwest France.

    Théophile H, Bégaud B, Martin K, Laporte JR, Capella D.

    Eur J Epidemiol. 2004;19(6):563-5.PMID: 15330129 [PubMed - indexed for MEDLINE]Related articles

    23.

    Merck Sharpe and Dohme versus Laporte.

    Laporte JR.

    Lancet. 2004 Jul 31-Aug 6;364(9432):416. No abstract available. PMID: 15288737 [PubMed - indexed for MEDLINE]Related articles

    24.

    Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents.

    Laporte JR, Ibáñez L, Vidal X, Vendrell L, Leone R.

    Drug Saf. 2004;27(6):411-20.PMID: 15144234 [PubMed - indexed for MEDLINE]Related articles

    25.

    Identification of GAPDH as a protein target of the saframycin antiproliferative agents.

    Xing C, LaPorte JR, Barbay JK, Myers AG.

    Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):5862-6. Epub 2004 Apr 12.PMID: 15079082 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Securing reproductive rights.

    Figueras A, Narváez E, Aguilera C, Laporte JR.

    Lancet. 2004 Mar 20;363(9413):989. No abstract available. PMID: 15043969 [PubMed - indexed for MEDLINE]Related articles

    27.

    [News about therapeutic use of Cannabis and endocannabinoid system]

    Duran M, Laporte JR, Capellà D.

    Med Clin (Barc). 2004 Mar 20;122(10):390-8. Review. Spanish. PMID: 15033046 [PubMed - indexed for MEDLINE]Related articles

    28.

    [Generic drug prescription at discharge from a hospital emergency service]

    Vallano A, Fortuny J, Arnau JM, Laporte JR.

    Med Clin (Barc). 2003 Nov 15;121(17):645-9. Spanish. PMID: 14642224 [PubMed - indexed for MEDLINE]Related articles

    29.

    [Liver toxicity of Camellia sinensis dried etanolic extract]

    Pedrós C, Cereza G, García N, Laporte JR.

    Med Clin (Barc). 2003 Nov 1;121(15):598-9. Spanish. No abstract available. PMID: 14622530 [PubMed - indexed for MEDLINE]Related articles

    30.

    Stimulating adverse drug reaction reporting: effect of a drug safety bulletin and of including yellow cards in prescription pads.

    Castel JM, Figueras A, Pedrós C, Laporte JR, Capellà D.

    Drug Saf. 2003;26(14):1049-55.PMID: 14583065 [PubMed - indexed for MEDLINE]Related articles

    31.

    Adverse effects of ACE inhibitors in patients with chronic heart failure and/or ventricular dysfunction : meta-analysis of randomised clinical trials.

    Agustí A, Bonet S, Arnau JM, Vidal X, Laporte JR.

    Drug Saf. 2003;26(12):895-908.PMID: 12959631 [PubMed - indexed for MEDLINE]Related articles

    32.

    The Cuban experience in focusing pharmaceuticals policy to health population needs: initial results of the National Pharmacoepidemiology Network (1996-2001).

    Diogène E, Pérez PJ, Figueras A, Furones JA, Debesa F, Laporte JR; National Pharmacoepidemiology Network.

    Pharmacoepidemiol Drug Saf. 2003 Jul-Aug;12(5):405-7.PMID: 12899116 [PubMed - indexed for MEDLINE]Related articles

    33.

    [Regulation of the evaluation process of multicentric clinical trials in Spain]

    Arnau JM, Fuentes I, Laporte JR.

    Med Clin (Barc). 2003 Jul 5;121(5):197; author reply 197. Spanish. No abstract available. PMID: 12867010 [PubMed - indexed for MEDLINE]Related articles

    34.

    Failures of the therapeutic chain as a cause of drug ineffectiveness.

    Figueras A, Laporte JR.

    BMJ. 2003 Apr 26;326(7395):895-6. No abstract available. PMID: 12714454 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Impact of analgesic drug-use guidelines for the management of postoperative pain: a drug utilization study.

    Vallano A, Llinares J, Amau JM, Martorell M, Girona L, Laporte JR.

    Int J Clin Pharmacol Ther. 2003 Apr;41(4):165-70.PMID: 12712962 [PubMed - indexed for MEDLINE]Related articles

    36.

    A new synthesis of cytoxazone and its diastereomers provides key initial SAR information.

    Carter PH, LaPorte JR, Scherle PA, Decicco CP.

    Bioorg Med Chem Lett. 2003 Apr 7;13(7):1237-9.PMID: 12657253 [PubMed - indexed for MEDLINE]Related articles

    37.

    Drug points: Dysgeusia and burning mouth syndrome by eprosartan.

    Castells X, Rodoreda I, Pedrós C, Cereza G, Laporte JR.

    BMJ. 2002 Nov 30;325(7375):1277. No abstract available. PMID: 12458247 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs.

    Ibáñez L, Pérez E, Vidal X, Laporte JR; Grup d'Estudi Multicènteric d'Hepatotoxicitat Aguda de Barcelona (GEMHAB).

    J Hepatol. 2002 Nov;37(5):592-600.PMID: 12399224 [PubMed - indexed for MEDLINE]Related articles

    39.

    Spontaneous reporting of adverse drug reactions in Cuba: integrating continuous education, training and research in a network approach.

    Debesa F, Jiménez G, Figueras A, Diogène E, Pérez Peña J, Avila J, Laporte JR.

    Br J Clin Pharmacol. 2002 Sep;54(3):335-6. No abstract available. PMID: 12236857 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data.

    Lewis SC, Langman MJ, Laporte JR, Matthews JN, Rawlins MD, Wiholm BE.

    Br J Clin Pharmacol. 2002 Sep;54(3):320-6.PMID: 12236853 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Regulatory decisions in a globalised world: the domino effect of phenylpropanolamine withdrawal in Latin America.

    Figueras A, Laporte JR.

    Drug Saf. 2002;25(10):689-93.PMID: 12167064 [PubMed - indexed for MEDLINE]Related articles

    42.

    Bioavailability of two metamizole (dipyrone) solutions as single doses of 2 g versus metamizole capsules.

    Artaza MA, Puerta JL, Ortiz R, Laporte JR.

    Int J Clin Pharmacol Ther. 2002 Jul;40(7):322-6.PMID: 12139210 [PubMed - indexed for MEDLINE]Related articles

    43.

    Therapeutic ineffectiveness: heads or tails?

    Figueras A, Pedrós C, Valsecia M, Laporte JR.

    Drug Saf. 2002;25(7):485-7.PMID: 12093306 [PubMed - indexed for MEDLINE]Related articles

    44.

    Health needs, drug registration and control in less developed countries--the Peruvian case.

    Figueras A, Vasquez S, Arnau JM, Laporte JR.

    Pharmacoepidemiol Drug Saf. 2002 Jan-Feb;11(1):63-4.PMID: 11998553 [PubMed - indexed for MEDLINE]Related articles

    45.

    [First spontaneous reports of adverse reactions to the new selective COX-2 non-steroidal anti-inflammatory drugs]

    Pedrós C, Cereza G, Laporte JR.

    Med Clin (Barc). 2002 Mar 30;118(11):415-7. Spanish. PMID: 11943104 [PubMed - indexed for MEDLINE]Related articles

    46.

    Case-population studies in pharmacoepidemiology.

    Capellà D, Pedrós C, Vidal X, Laporte JR.

    Drug Saf. 2002;25(1):7-19. Review.PMID: 11820909 [PubMed - indexed for MEDLINE]Related articles

    47.

    Therapeutic consultation centres are helpful in developing countries.

    Figueras A, Laporte JR.

    BMJ. 2002 Jan 26;324(7331):236. No abstract available. PMID: 11809654 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Interaction between orlistat and antihypertensive drugs.

    Valescia ME, Malgor LA, Farías EF, Figueras A, Laporte JR.

    Ann Pharmacother. 2001 Nov;35(11):1495-6. No abstract available. PMID: 11724110 [PubMed - indexed for MEDLINE]Related articles

    49.

    Appropriate initiation of the strand exchange reaction promoted by RecA protein requires ATP hydrolysis.

    Zhang Z, Yoon D, LaPorte JR, Chen J.

    J Mol Biol. 2001 May 25;309(1):29-43.PMID: 11491297 [PubMed - indexed for MEDLINE]Related articles

    50.

    Agranulocytosis associated with calcium dobesilate clinical course and risk estimation with the case-control and the case-population approaches.

    Ibáñez L, Ballarín E, Vidal X, Laporte JR.

    Eur J Clin Pharmacol. 2000 Dec;56(9-10):763-7.PMID: 11214789 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...